Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Iovance Biotherapeutics Inc patents

Recent patent applications related to Iovance Biotherapeutics Inc. Iovance Biotherapeutics Inc is listed as an Agent/Assignee. Note: Iovance Biotherapeutics Inc may have other listings under different names/spellings. We're not affiliated with Iovance Biotherapeutics Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "I" | Iovance Biotherapeutics Inc-related inventors

Restimulation of cryopreserved tumor infiltrating lymphocytes

The present disclosure provides methods for re-stimulating til populations that lead to improved phenotype and increased metabolic health of the tils and provides methods of assaying for til populations to determine suitability for more efficacious infusion after re-stimulation.. . ... Iovance Biotherapeutics Inc

Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

The present invention provides improved and/or shortened methods for expanding tils and producing therapeutic populations of tils, including novel methods for expanding til populations in a closed system that lead to improved efficacy, improved phenotype, and increased metabolic health of the tils in a shorter time period, while allowing for reduced microbial contamination as well as decreased costs. Such tils find use in therapeutic treatment regimens.. ... Iovance Biotherapeutics Inc

Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion

In some embodiments, compositions and methods relating to isolated artificial antigen presenting cells (aapcs) are disclosed, including aapcs comprising a myeloid cell transduced with one or more viral vectors, such as a molm-14 or a em-3 myeloid cell, wherein the myeloid cell endogenously expresses hla-ab/c, icos-l, and cd58, and wherein the one or more viral vectors comprise a nucleic acid encoding cd86 and a nucleic acid encoding 4-1bbl and/or ox40l and transduce the myeloid cell to express cd86 and 4-1bbl and/or ox40l proteins. In some embodiments, methods of expanding tumor infiltrating lymphocytes (tils) with aapcs and methods of treating cancers using tils after expansion with aapcs are also disclosed.. ... Iovance Biotherapeutics Inc

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Iovance Biotherapeutics Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Iovance Biotherapeutics Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by